公司资料
National Research Corporation 股价、新闻与催化剂
- 股票代码:
- NRC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
21.32 USD (+0.61%)
收盘价
最后更新: 2026年10月1日
441M USD
市值
股价为何变动
截至 2026年10月1日，NRC 上涨 0.61%，收于 $21.32。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Healthcare Experience Improvement Company
NRC Health provides healthcare organizations with consumer, patient, employee, and market insights intended to improve experience, loyalty, reputation, and organizational performance.
Continuous Feedback and Insight
The company collects and analyzes feedback across the care journey rather than relying only on isolated surveys. Its tools help health systems identify service gaps, understand preferences, and prioritize actions at facility, department, and clinician levels.
Human Understanding Platform
NRC Health combines experience data, consumer intelligence, analytics, and workflow tools to help clients understand the people they serve. The platform is designed to translate insights into operational actions and more personalized interactions.
Leadership and Governance Services
The Governance Institute and related advisory offerings provide research, education, benchmarking, and engagement for healthcare boards and executives. These services connect patient-experience improvement with broader leadership and governance priorities.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。